CHRISTA HOOVER: Open Payments
NPI 1083241699 · LEAWOOD, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$836 in 40 payments from 14 companies in 2025. Trend: 2023 $436 · 2024 $329 · 2025 $836
Food & beverage: $836
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 7 | $192 |
| GlaxoSmithKline, LLC. | 9 | $188 |
| Melinta Therapeutics, LLC | 6 | $94 |
| Amgen Inc. | 3 | $61 |
| ABBVIE INC. | 3 | $58 |
| Grifols USA, LLC | 2 | $48 |
| Philips North America LLC | 2 | $41 |
| Insmed, Inc. | 2 | $32 |
| Paratek Pharmaceuticals, Inc. | 1 | $28 |
| Axsome Therapeutics, Inc. | 1 | $22 |
Products named: DUPIXENT, NUCALA, Kimyrsa, DALVANCE, Prolastin-C Liquid, TEZSPIRE, Arikayce, NUZYRA.
Industry payments across KS — which companies pay providers there.
